SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-21-002816
Filing Date
2021-11-22
Accepted
2021-11-22 16:49:03
Documents
81
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 AXIM FORM 10-Q axim-20210930.htm   iXBRL 10-Q 1629433
2 CERTIFICATION axim_ex311.htm EX-31 9740
3 CERTIFICATION axim_ex312.htm EX-31 9875
4 CERTIFICATION axim_ex321.htm EX-32 3805
5 CERTIFICATION axim_ex322.htm EX-32 3709
11 IMAGE axim_10qimg1.jpg GRAPHIC 5142
  Complete submission text file 0001096906-21-002816.txt   7089428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20210930_cal.xml EX-101.CAL 51726
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20210930_def.xml EX-101.DEF 236444
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20210930_lab.xml EX-101.LAB 442740
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20210930_pre.xml EX-101.PRE 384105
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20210930.xsd EX-101.SCH 85157
12 EXTRACTED XBRL INSTANCE DOCUMENT axim-20210930_htm.xml XML 937710
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 211433220
SIC: 2834 Pharmaceutical Preparations